Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
J Cardiothorac Vasc Anesth ; 36(3): 776-784, 2022 03.
Article in English | MEDLINE | ID: mdl-33451953

ABSTRACT

Spinal cord ischemia (SCI) associated with aortic surgery is well-described; however, SCI after cardiac surgery not involving the aorta is an unusual and underappreciated phenomenon. The authors reviewed the literature and found 54 case reports of perioperative spinal cord ischemia in nonaortic surgery. The severity of its implications is evidenced by the fact that 14 patients died, 22 had no recovery, and seven had only partial recovery. Various types of cardiac surgery have reported this complication including coronary artery bypass grafting (CABG), off-pump CABG, valve surgeries, combination valve and CABG surgeries, and transcatheter aortic valve procedures. Patient comorbidities, such as high blood pressure, hypercholesterolemia, diabetes, and peripheral vascular disease, also may play a role in the development of this adverse outcome. The authors review the literature to define further possible mechanisms, surgical techniques, and patient factors that could contribute to the risk of perioperative SCI after cardiac surgery.


Subject(s)
Coronary Artery Bypass, Off-Pump , Spinal Cord Ischemia , Aorta , Aortic Valve/surgery , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass, Off-Pump/methods , Humans , Risk Factors , Spinal Cord Ischemia/diagnostic imaging , Spinal Cord Ischemia/etiology , Treatment Outcome
3.
Anesth Analg ; 133(5): 1180-1186, 2021 11 01.
Article in English | MEDLINE | ID: mdl-34415867

ABSTRACT

BACKGROUND: Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse reaction to heparin. Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) are routinely anticoagulated with heparin before the initiation of bypass. Heparin is contraindicated, however, in patients with acute HIT, and alternatives to routine practice are often used. While guidelines have recently been published addressing this topic 10, there remains variance between institutions in how these cases are treated. Our goal was to better delineate practice trends in the diagnosis and management of HIT patients requiring CPB. METHODS: We surveyed members of the Society of Cardiovascular Anesthesiologists (SCA) and the American Society for Extracorporeal Technology (AmSECT) using an online survey tool. RESULTS: We received 304 completed surveys (5.8% response rate), 75% completed by an anesthesiologist, and 24% by a perfusionist. The majority of respondents used clinical history and/or antibody testing (71% and 63%, respectively) to diagnose HIT. Seventy-five percent of respondents reported using an institutional protocol for HIT-CPB cases. Most respondents (89%) reported having at least 1 case in the last 3 years, with a total case experience of at least 785 cases (785 = the minimum number of cases in each case volume category × the number of respondents choosing that category). The strategy recommended in published guidelines, bivalirudin, was the most commonly reported alternative anticoagulation strategy (75%) used by respondents in HIT cases, with most (83%) using the activated clotting time (ACT) to monitor anticoagulation. CONCLUSIONS: Most responding SCA and AmSECT members reported that their institution used a protocol or guideline for HIT/CPB cases, and most guidelines directed the use of bivalirudin as an alternative anticoagulant. Various other methods such as plasmapheresis are also being used with success in this patient population. Further research, including comparison studies of alternative anticoagulant strategies, is required to elucidate the best approach to these difficult cases.


Subject(s)
Anticoagulants/administration & dosage , Cardiac Surgical Procedures , Cardiopulmonary Bypass , Heparin/adverse effects , Practice Patterns, Physicians'/trends , Thrombocytopenia/therapy , Anticoagulants/immunology , Cardiac Surgical Procedures/adverse effects , Cardiopulmonary Bypass/adverse effects , Contraindications, Procedure , Drug Monitoring/trends , Drug Substitution/trends , Guideline Adherence/trends , Health Care Surveys , Heparin/immunology , Hirudins , Humans , Peptide Fragments/therapeutic use , Plasmapheresis/trends , Practice Guidelines as Topic , Recombinant Proteins/therapeutic use , Risk Assessment , Risk Factors , Thrombocytopenia/chemically induced , Thrombocytopenia/diagnosis , Thrombocytopenia/immunology , Whole Blood Coagulation Time/trends
5.
A A Pract ; 14(8): e01246, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32643911

ABSTRACT

A 34-year-old man presented with a large right ventricular (RV) intracardiac mass obstructing RV inflow and outflow as well as a concomitant pericardial effusion displaying physiological signs of tamponade. The patient underwent awake femorofemoral cannulation for cardiopulmonary bypass (CPB) under regional anesthesia with initiation of CPB before induction of general anesthesia. This unconventional approach avoided hemodynamic perturbations in this high-risk patient. Regional anesthesia provided predictable analgesia compared to local infiltration for improved toleration of cannulation.


Subject(s)
Anesthesia, Conduction/adverse effects , Cardiopulmonary Bypass/methods , Sarcoma/surgery , Adult , Echocardiography, Transesophageal/methods , Heart Neoplasms/complications , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/pathology , Hemodynamics , Humans , Magnetic Resonance Imaging/methods , Male , Treatment Outcome , Ultrasonography, Interventional/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...